IGF2BP1-HAX-1 positive feedback loop-mediated HAX-1 overexpression blocks autophagic flux and promotes chemoresistance in nasopharyngeal carcinoma

被引:0
作者
Zhang, Siyu [1 ,2 ]
Gu, Miao [1 ,2 ]
Yin, Haimeng [1 ,2 ]
Pan, Si [1 ,2 ]
Xie, Haijing [1 ,2 ]
Chen, Wenhui [1 ,2 ]
Gul, Sheraz [3 ,4 ]
Zhao, Yue [5 ,6 ]
Wang, Zhefang [8 ]
Zheng, Wenjie [7 ]
You, Yiwen [1 ,2 ]
You, Bo [1 ,2 ]
机构
[1] Nantong Univ, Affiliated Hosp, Dept Otorhinolaryngol Head & Neck Surg, Xisi Rd 20, Nantong 226019, Jiangsu, Peoples R China
[2] Nantong Univ, Affiliated Hosp, Inst Otolaryngol Head & Neck Surg, Xisi Rd 20, Nantong 226019, Jiangsu, Peoples R China
[3] Fraunhofer Inst Translat Med & Pharmacol ITMP, Hamburg, Germany
[4] Fraunhofer Cluster Excellence Immune Mediated Dis, Hamburg, Germany
[5] Univ Cologne, Fac Med, Dept Gen Visceral & Canc Surg, Cologne, Germany
[6] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[7] Nantong Univ, Affiliated Hosp, Med Sch, Res Ctr Clin Med, Nantong 226019, Jiangsu, Peoples R China
[8] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Plast & Reconstruct Surg, Jiefang Rd 88, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Autophagic flux; Carcinoma; Chemoresistance; HAX-1; IGF2BP1; Nasopharyngeal; Rab7a; CANCER; EFFECTOR;
D O I
10.1007/s00018-025-05604-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autophagy is associated with chemoresistance, which is the leading cause of failure in chemotherapeutic treatments. Among the various aspects of autophagy, autophagic flux serves as a critical indicator for evaluating the dynamic processes involved.We report herein that the multifunctional protein HAX-1 promotes chemoresistance by effectively blocking the fusion of autophagosomes with lysosomes. Complementary mass spectrometric and functional studies also demonstrated that HAX-1 recruits NEDD4 to promote Rab7a degradation and inhibits binding of Rab7a with SNAREs by competitively binding to it. Furthermore, HAX-1 binds IGF2BP1 mRNA, thereby contributing to its stability and translation. Moreover, IGF2BP1 enhanced HAX-1 m6A methylation, thereby enhancing its stability. By way of in-vivo and in-vitro experiments, we confirmed the positive role of the IGF2BP1-HAX-1 feedback loop in chemoresistance. Taken together, our findings provide evidence that monitoring of HAX-1, IGF2BP1, and SQSTM1 levels can serve as useful predictors of clinical outcome and chemoresistance risk. In addition, our data provide new insights into the clinical applications of therapies related to autophagic flux and its associated molecular network in targeting cisplatin chemoresistance in nasopharyngeal carcinoma.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma
    Ali, Sakhawat
    Tahir, Muhammad
    Khan, Aamir Ali
    Chen, Xue Chai
    Ling, Ma
    Huang, Yinghui
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (05)
  • [2] Coupling caspase cleavage and proteasomal degradation of proteins carrying PEST motif
    Belizario, Jose E.
    Alves, Juliano
    Garay-Malpartida, Miguel
    Occhiucci, Joao Marcelo
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2008, 9 (03) : 210 - 220
  • [3] N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis
    Chen, Binbin
    Huang, Ying
    He, Shuiqing
    Yu, Peng
    Wu, Lirong
    Peng, Hao
    [J]. CELL CHEMICAL BIOLOGY, 2023, 30 (02) : 144 - +
  • [4] NCCN Guidelines® Insights Head and Neck Cancers, Version 1.2018 Featured Updates to the NCCN Guidelines
    Colevas, A. Dimitrios
    Yom, Sue S.
    Pfister, David G.
    Spencer, Sharon
    Adelstein, David
    Adkins, Douglas
    Brizel, David M.
    Burtness, Barbara
    Busse, Paul M.
    Caudell, Jimmy J.
    Cmelak, Anthony J.
    Eisele, David W.
    Fenton, Moon
    Foote, Robert L.
    Gilbert, Jill
    Gillison, Maura L.
    Haddad, Robert I.
    Hicks, Wesley L., Jr.
    Hitchcock, Ying J.
    Jimeno, Antonio
    Leizman, Debra
    Maghami, Ellie
    Mell, Loren K.
    Mittal, Bharat B.
    Pinto, Harlan A.
    Ridge, John A.
    Rocco, James
    Rodriguez, Cristina P.
    Shah, Jatin P.
    Weber, Randal S.
    Witek, Matthew
    Worden, Frank
    Zhen, Weining
    Burns, Jennifer L.
    Darlow, Susan D.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05): : 479 - 490
  • [5] Nasopharyngeal Carcinoma: Chemotherapy or No Chemotherapy?
    Ernani, Vinicius
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (10) : 607 - +
  • [6] HAX-1: A multifunctional protein with emerging roles in human disease
    Fadeel, Bengt
    Grzybowska, Ewa
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (10): : 1139 - 1148
  • [7] HAX1-dependent control of mitochondrial proteostasis governs neutrophil granulocyte differentiation
    Fan, Yanxin
    Murgia, Marta
    Linder, Monika, I
    Mizoguchi, Yoko
    Wang, Cong
    Lyszkiewicz, Marcin
    Zietara, Natalia
    Liu, Yanshan
    Frenz, Stephanie
    Sciuccati, Gabriela
    Partida-Gaytan, Armando
    Alizadeh, Zahra
    Rezaei, Nima
    Rehling, Peter
    Dennerlein, Sven
    Mann, Matthias
    Klein, Christoph
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (09)
  • [8] Chemotherapy and chemo-resistance in nasopharyngeal carcinoma
    Guan, Shuzhen
    Wei, Jinrui
    Huang, Lingkun
    Wu, Lichuan
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
  • [9] m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
    Huang, Huilin
    Weng, Hengyou
    Chen, Jianjun
    [J]. CANCER CELL, 2020, 37 (03) : 270 - 288
  • [10] Stress management by autophagy: Implications for chemoresistance
    Huang, Zhao
    Zhou, Li
    Chen, Zhibin
    Nice, Edouard C.
    Huang, Canhua
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 23 - 32